The Matrix Biology Institute is a key resource for HYLACO, LLC.

Scientist at work in labThe Matrix Biology Institute (MBI) was founded in 1982 by Endre A. Balazs, M.D. and Janet L. Denlinger, Ph.D. At that time both of them were members of the faculty of the Eye Research Department at the College of Physicians and Surgeons of Columbia University of New York. Endre Balazs, Professor Emeritus of Columbia University of New York is the Chief Scientific Officer and Chair of the board of MBI, and Janet Denlinger is the President.

The objective of MBI is to carry out research on the structure, function and therapeutic use of hyaluronan, one of the molecular building blocks of the intercellular matrix. Since its inception, MBI has carried out and supported research projects on the biological function of the intercellular matrix (biomatrix). The results of this research are published in international research journals.

General Purposes:

More Info

MBI is incorporated in the State of Delaware, USA, for charitable, scientific and educational purposes within the meaning of Section 501(c)(3) of the Internal Revenue Code of 1986 as amended. The Corporation is not organized for profit and has no authority to issue capital stock.

Research Laboratories
The Institute operates its own research laboratories in biochemistry, cytology, biophysics and tissue culture at 725 River Road, Suite 205, Edgewater, New Jersey 07020. www.matrixbiologyinstitute.org